Keyword

PT2385

Description: PT2385 is a small-molecule antagonist of hypoxia-inducible factor 2 alpha studied as a targeted treatment for cancer and other hypoxia-related conditions.
OpenAlex ID: keywords/pt2385
2016 · Eli M. Wallace, James P. Rizzi, et al. · Cancer Research · 374
2017 · Olga Martínez-Sáez, Pablo Gajate Borau, et al. · Critical Reviews in Oncology/Hematology · 116
2017 · Hirofumi Yoshino, Nijiro Nohata, et al. · Cancer Research · 95
2020 · Xiaotong Cheng, Maria Prange-Barczynska, et al. · Journal of Clinical Investigation · 64
2016 · Hyejin Cho, William G. Kaelin · Cold Spring Harbor Symposia on Quantitative Biology · 64
2021 · Hyun Seung Ban, Yoshikazu Uto, et al. · Expert Opinion on Therapeutic Patents · 44
2023 · Roy Strowd, Benjamin Ellingson, et al. · Journal of Neuro-Oncology · 43
2018 · Jaclyn J Renfrow, Michael H Soike, et al. · Future Medicinal Chemistry · 43
2020 · Camilla U. Persson, Kristoffer von Stedingk, et al. · Experimental Cell Research · 41
2018 · Rohan Garje, Josiah J. An, et al. · International Journal of Molecular Sciences · 41
2018 · Cen Xie, Xiaoxia Gao, et al. · Drug Metabolism and Disposition · 37
2025 · Felipe I. Espinoza, Stoyan Tankov, et al. · Cellular and Molecular Life Sciences · 27
Works count: 122
Citation count: 3,136
Year
Topic
Type